Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates
The Journal of Gene Medicine2005Vol. 7(2), pp. 228–236
Citations Over TimeTop 10% of 2005 papers
Elena Fattori, Manuela Cappelletti, Immacolata Zampaglione, Carmela Mennuni, Francesco Calvaruso, Mirko Arcuri, Gabriella Rizzuto, Patrizia Costa, Gemma Perretta, Gennaro Ciliberto, Nicola La Monica
Abstract
The modified EPO gene yields higher levels of circulating transgene product and a more significant biological effect than the wild-type gene in all the species tested, thus showing great potential in clinically developable gene therapy approaches for EPO delivery.
Related Papers
- → Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy(2023)9 cited
- → Intranasal Delivery of Adenoviral and AAV Vectors for Transduction of the Mammalian Peripheral Olfactory System(2019)8 cited
- Targeting of drugs 5 : strategies for oligonucleotide and gene delivery in therapy(1996)
- → Engineering Viral Vectors for Acoustically Targeted Gene Delivery(2021)11 cited
- → Gene therapy for cardiovascular applications(2005)